Vanguard Capital Management’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
Other funds holding BMY
Vanguard Capital Management's BMY Position: Q2 2026 in Review
Vanguard Capital Management increased its Bristol-Myers Squibb (BMY) stake by 0.77% in Q2 2026, buying an estimated $58.4M and bringing the position to 133,337,856 shares worth $7.68B. The position accounts for 0.16% of the portfolio, ranked #101.
Vanguard Capital Management first reported a position in BMY in Q1 2026 and has held it in 2 quarters since. The position peaked at $8.03B in Q1 2026. 2,401 funds tracked by Wall St. Rank hold BMY as of Q2 2026.
- Vanguard Capital Management held 133,337,856 shares of Bristol-Myers Squibb worth $7.68B as of Q2 2026.
- Vanguard Capital Management bought 1,017,616 Bristol-Myers Squibb shares in Q2 2026, an estimated $58.4M.
- Bristol-Myers Squibb made up 0.16% of Vanguard Capital Management's portfolio in Q2 2026, its #101 holding.
- Vanguard Capital Management first reported a position in Bristol-Myers Squibb in Q1 2026 and has held it in 2 quarters since.
- Vanguard Capital Management's Bristol-Myers Squibb position peaked at $8.03B in Q1 2026.
- 2,401 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.
Based on Vanguard Capital Management's 13F filing for Q2 2026, filed 13 Aug 2026.